• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-4MEF filed by D8 Holdings Corp.

    9/15/21 5:13:12 PM ET
    $DEH
    Business Services
    Finance
    Get the next $DEH alert in real time by email
    S-4MEF 1 ea147390-s4mef_d8holdings.htm REGISTRATION STATEMENT

    As filed with the Securities and Exchange Commission on September 15, 2021

    Registration No. 333-        

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM S-4

     

    REGISTRATION STATEMENT

    UNDER THE SECURITIES ACT OF 1933

     

     

     

    D8 Holdings Corp.*

    (Exact name of Registrant as specified in its charter)

     

     

     

    Cayman Islands   6770   N/A
    (State or other jurisdiction of
    incorporation or organization)
      (Primary standard industrial
    classification code number)
      (I.R.S. Employer
    Identification Number)

     

    Unit 1008, 10/F, Champion Tower

    3 Garden Road

    Central, Hong Kong

    +852 3973 5500

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

    Edward Truitt

    Maples Fiduciary Services (Delaware) Inc.

    4001 Kennett Pike, Suite 302

    Wilmington, Delaware 19807

    Telephone: (302) 731-1612

    (Name, address, including zip code, and telephone number, including area code, of agent for service)

     

     

     

    With copies to:

     

    Joel L. Rubinstein

    Elliott Smith

    White & Case LLP

    1221 Avenue of the Americas

    New York, New York 10020

    Tel: (212) 819-8200

     

    Shari Seymour

    Maples and Calder

    P.O. Box 309, Ugland House

    Grand Cayman

    KYI-1104

    Cayman Islands

    Tel: (245) 949-8066

     

    Edwin C. Pease

    Andrew D. Thorpe

    Melissa V. Frayer

    Mintz, Levin, Cohn, Ferris, Glovsky
    and Popeo, P.C.

    One Financial Center

    Boston, MA 02111

    Tel: (617) 542-6000

     

    Approximate date of commencement of proposed sale of the securities to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Agreement and Plan of Merger described in the included proxy statement/prospectus have been satisfied or waived.

     

    If the securities being registered on this form are being offered in connection with the formation of a holding company and there is compliance with General Instruction G, please check the following box.  ☐

     

    If this form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, as amended (the “Securities Act”), check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☒ Registration No. 333-257055

     

    If this form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.  ☐

     

     

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

     

    Large accelerated filer   ☐   Accelerated filer   ☐
           
    Non-accelerated filer   ☐   Smaller reporting company   ☒
           
            Emerging growth company   ☒

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  ☐

     

    If applicable, place an X in the box to designate the appropriate rule provision relied upon in conducting this transaction:

     

    Exchange Act Rule 13c-4(i) (Cross-Border Issuer Tender Offer)  ☐

     

    Exchange Act Rule 14d-1(d) (Cross-Border Third-Party Tender Offer)  ☐

     

    *Prior to the consummation of the business combination described herein, the Registrant intends to effect a deregistration under Section 206 of the Cayman Islands Companies Act (As Revised) and a domestication under Section 388 of the Delaware General Corporation Law, pursuant to which the Registrant’s jurisdiction of incorporation will be changed from the Cayman Islands to the State of Delaware (the “Domestication”). All securities being registered will be issued by D8 Holdings Corp. (after its domestication as a corporation incorporated in the State of Delaware), the continuing entity following the Domestication, which will be renamed “Vicarious Surgical Inc.” (“New Vicarious Surgical”).

     

     

     

     

    CALCULATION OF REGISTRATION FEE

     

    Title of Each Class of Security To Be Registered  Amount To Be
    Registered
       Proposed
    Maximum
    Offering Price
    Per Security
       Proposed
    Maximum
    Aggregate
    Offering Price
       Amount of
    Registration
    Fee
     
    Class A Common Stock(2)(3)(6)   650,742   $9.95(1)  $6,474,882.90(1)  $706.41(1)
    Class B Common Stock(2)(4)(6)   75,564   $9.95(7)  $751,861.80(7)  $82.03(7)
    Class A Common Stock issuable upon the conversion of Class B Common Stock(2)(5)(6)   75,564    (8)   (8)   (8)
    Total            $7,226,744.70   $788.44 

     

      (1) Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Class A Ordinary Shares on The New York Stock Exchange on September 13, 2021 (such date was within five business days prior to the date of the initial filing of this Registration Statement) in accordance with Rule 457(f)(1) under the Securities Act.
      (2) The Registrant previously registered an aggregate of 156,646,827 shares of its common stock, which includes (i) 110,769,991 shares of its Class A common stock, par value $0.0001 per share, estimated to be issued in connection with the business combination with Vicarious Surgical Inc. (“Vicarious Surgical”) as described in the Prior Registration Statement (as defined below), (ii) 19,726,836 shares of its Class B common stock, par value $0.0001 per share, estimated to be issued in connection with the business combination with Vicarious Surgical (including 19,726,836 shares of its Class A common stock issuable upon the conversion of its Class B common stock) and (iii) 26,150,000 shares of its Class A common stock issuable upon exercise of its redeemable warrants on its Registration Statement on Form S-4, as amended (File No. 333-257055) (the “Prior Registration Statement”), which was declared effective by the U.S. Securities and Exchange Commission on August 9, 2021.
      (3) In accordance with Rule 462(b) under the Securities Act, 650,742 additional shares of the Registrant’s Class A common stock to be issued by the Registrant to Vicarious Surgical securityholders upon consummation of the business combination, including shares issuable pursuant to outstanding options and warrants based on an exchange ratio that incorporates certain assumptions about Vicarious Surgical’s cash and debt at the closing of the business combination are hereby registered.
      (4)

    In accordance with Rule 462(b) under the Securities Act, 75,564 additional shares of the Registrant’s Class B common stock to be issued by the Registrant to Vicarious Surgical securityholders upon consummation of the business combination are hereby registered.

      (5)

    In accordance with Rule 462(b) under the Securities Act, 75,564 additional shares of the Registrant’s Class A common stock issuable upon the conversion of 75,564 additional shares of the Registrant’s Class B common stock by the Registrant to Vicarious Surgical securityholders upon consummation of the business combination are hereby registered.

      (6) Pursuant to Rule 416(a) of the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.
      (7) Estimated solely for the purpose of calculating the registration fee, based on the average of the high and low prices of the Class A Ordinary Shares on The New York Stock Exchange on September 13, 2021 (such date was within five business days prior to the date of the initial filing of this Registration Statement) in accordance with Rule 457(f)(1) under the Securities Act. For purposes of calculating the registration fee, the Class B common stock is treated as having the same value as the Class A common stock as each share of Class B common stock is convertible into one share of Class A common stock.
      (8) Pursuant to Rule 457(i) promulgated under the Securities Act, no separate registration fee is required.

     

    This registration statement will become effective automatically upon filing with the Securities and Exchange Commission pursuant to Rule 462(b) under the Securities Act of 1933, as amended.

     

    As used in this Registration Statement, the term “Registrant” refers to the Registrant (a Cayman Islands exempted company) prior to the Domestication and to New Vicarious Surgical (a Delaware corporation) following the Domestication.

     

     

     

     

     

     

    EXPLANATORY NOTE

     

    Pursuant to its Registration Statement on Form S-4 (Registration No. 333-257055) (the “Prior Registration Statement”), declared effective as of August 9, 2021, D8 Holdings Corp. (the “Registrant”) registered an aggregate of 156,646,827 shares of its common stock, which includes (i) 110,769,991 shares of its Class A common stock estimated to be issued in connection with the Business Combination (as defined in the Prior Registration Statement), (ii) 19,726,836 shares of its Class B common stock estimated to be issued in connection with the Business Combination (including 19,726,836 shares of its Class A common stock issuable upon the conversion of its Class B common stock) and (iii) 26,150,000 shares of its Class A common stock issuable upon exercise of its redeemable warrants and paid an aggregate fee of $173,757.42. The Registrant is filing this Registration Statement on Form S-4 pursuant to General Instruction K to Form S-4 and Rule 462(b) of the Securities Act of 1933, as amended, solely to register 650,742 additional shares of its Class A common stock and 75,564 additional shares of its Class B common stock for issuance in connection with the consummation of the merger transactions contemplated by the Agreement and Plan of Merger, dated as of April 15, 2021, by and among the Registrant, Snowball Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Registrant, Vicarious Surgical Inc., a Delaware corporation and Adam Sachs, in his capacity as the stockholder representative, as well as 75,564 additional shares of its Class A common stock issuable upon the conversion of the 75,564 additional shares of Class B common stock. In connection with the registration of additional shares of its common stock, the Registrant is paying an additional registration fee of $788.44.

     

    STATEMENT OF INCORPORATION BY REFERENCE

     

    This Registration Statement incorporates by reference the contents of the Prior Registration Statement, including all amendments, supplements and exhibits thereto and all information incorporated or deemed to be incorporated by reference therein. Additional opinions and consents required to be filed with this Registration Statement are listed on the Exhibit Index included with this Registration Statement.

     

     

     

     

    PART II

     

    INFORMATION NOT REQUIRED IN PROSPECTUS

     

    Exhibit Index

     

    Exhibit
    Number
     

    Description

       
    5.1*   Opinion of White & Case LLP
       
    23.1*   Consent of Deloitte & Touche LLP
       
    23.2*   Consent of WithumSmith+Brown, PC
       
    23.2*   Consent of White & Case LLP (included in Exhibit 5.1).
       
    24.1**   Power of Attorney.

     

    * Filed herewith.

     

    **Previously filed with the registrant’s Registration Statement on Form S-4 (No. 333-257055), as amended, which was initially filed with the Securities and Exchange Commission on June 11, 2021.

     

    II-1

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hong Kong on the 15th day of September, 2021.

     

      D8 HOLDINGS CORP.
       
      By:  /s/ David Chu
        David Chu
        Chief Executive Officer

     

    Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

     

    Name   Title   Date
             
    /s/ David Chu   Chief Executive Officer and Director   September 15, 2021
    David Chu   (Principal Executive Officer)    
             
    *   Chief Financial Officer   September 15, 2021
    Robert Kirby   (Principal Financial and Accounting Officer)    
             
    *   President and Director   September 15, 2021
    Donald Tang        
             
    *   Director   September 15, 2021
    Michael Kives        
             
    *   Director   September 15, 2021
    Fred Langhammer        
             
    *   Director   September 15, 2021
    Terry Lundgren        
             
    *   Director   September 15, 2021
    David Ho        

     

    *By:/s/ David Chu  
    Name: David Chu  
    Title:Attorney-in-fact  

     

    II-2

     

    AUTHORIZED REPRESENTATIVE

     

    Pursuant to the requirements of Section 6(a) of the Securities Act of 1933, the undersigned has signed this registration statement, solely in its capacity as the duly authorized representative of D8 Holdings Corp., in the City of Newark, Delaware, on the 15th day of September, 2021.

     

      By: /s/ Donald J. Puglisi
      Name:  Donald J. Puglisi
      Title: Managing Director

     

     

    II-3

     

     

    Get the next $DEH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $DEH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $DEH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by D8 Holdings Corp.

      SC 13G - Vicarious Surgical Inc. (0001812173) (Subject)

      9/30/21 5:27:18 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form SC 13D filed by D8 Holdings Corp.

      SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)

      9/30/21 5:25:24 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form SC 13D filed by D8 Holdings Corp.

      SC 13D - Vicarious Surgical Inc. (0001812173) (Subject)

      9/28/21 5:02:17 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Khosla Ventures V, L.P. bought $3,333,340 worth of shares (333,334 units at $10.00) (Amendment)

      4/A - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/18/21 6:49:35 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form 3: New insider Khosla Ventures Seed C, L.P. claimed ownership of 20,622,788 shares (Amendment)

      3/A - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/18/21 6:47:08 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form 3 filed by new insider Patnaik Shrikant

      3 - Vicarious Surgical Inc. (0001812173) (Issuer)

      10/1/21 8:14:50 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Vicarious Surgical Business Combination Approved; Stock to Begin Trading on the New York Stock Exchange as "RBOT"

      Vicarious Surgical to debut on NYSE as a disruptive next-generation surgical robotics company Approximately $220 million in gross cash proceeds to catalyze advancement of Vicarious Surgical's robotic technology, clinical programs, and strategic business initiatives Combined company to trade on NYSE under ticker symbol "RBOT" Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company") (NYSE:RBOT, RBOT WS))), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that the shareholders of D8 Holdings Corp. ("D8") (NYSE:DEH, DEH, DEH WS))), have approved the previously announced bus

      9/15/21 4:50:00 PM ET
      $BDX
      $DEH
      $NFH
      Medical/Dental Instruments
      Health Care
      Business Services
      Finance
    • Vicarious Surgical Inc. and D8 Holdings Corp. Announce Additional PIPE Commitments

      Vicarious Surgical Inc. ("Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, and D8 Holdings Corp. ("D8") (NYSE:DEH), a special purpose acquisition company, today announced that they have secured $27 million in additional commitments for a private placement of common stock ("PIPE") in support of their business combination transaction, bringing the aggregate amount of PIPE commitments to $142 million, and the total anticipated gross proceeds of the business combination to approximately $487 million (assuming no redemptions). The additional commitments ensure that

      9/9/21 8:34:00 PM ET
      $BDX
      $DEH
      $NFH
      Medical/Dental Instruments
      Health Care
      Business Services
      Finance
    • Vicarious Surgical CEO Adam Sachs to Present at Surgical Disruptive Technology Summit

      WALTHAM, Mass., May 27, 2021 /PRNewswire/ -- Vicarious Surgical Inc. ("Vicarious" or "Vicarious Surgical" or the "Company"), a next-generation robotics technology company seeking to improve both cost and efficiency of surgical procedures as well as patient outcomes, today announced that Adam Sachs, Co-Founder and Chief Executive Officer of Vicarious Surgical, will participate in a panel discussion on the future of surgical robots at the Surgical Disruptive Technology Summit in Houston, Texas on June 4, 2021. Presentation Details Title:     Surgical Robotics: The Next 5 YearsD

      5/27/21 4:07:00 PM ET
      $DEH
      Business Services
      Finance

    $DEH
    SEC Filings

    See more
    • D8 Holdings Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Vicarious Surgical Inc. (0001812173) (Filer)

      10/20/21 4:10:10 PM ET
      $DEH
      Business Services
      Finance
    • SEC Form S-1 filed by D8 Holdings Corp.

      S-1 - Vicarious Surgical Inc. (0001812173) (Filer)

      10/15/21 4:09:48 PM ET
      $DEH
      Business Services
      Finance
    • D8 Holdings Corp. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year (Amendment)

      8-K/A - Vicarious Surgical Inc. (0001812173) (Filer)

      9/23/21 4:07:29 PM ET
      $DEH
      Business Services
      Finance